- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Alternative Capital and Credit Funds
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Investment Funds and Asset Management
- Leveraged Finance
- Mergers and Acquisitions
- Middle East and Islamic Finance and Investment
- Private Equity
- Real Estate
- Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Insurance Coverage and Recovery
- Intellectual Property, Patent, Trademark and Copyright Litigation
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- Careers
- News & Insights
- About
- Languages
News 129 results
In the News · Source: Law360
July 24, 2020
Zack Harmon, Sumon Dantiki and Seth Lundy discuss issues at play in the development of a COVID-19 vaccine.
In the News · Source: 340B Report
Cases & Deals
June 1, 2020
Alexion Pharmaceuticals Secures Favorable Resolution and Termination of Challenge to SOLIRIS® Patents
In the News · Source: Pink Sheet
May 5, 2020
Lisa Dwyer discusses the remdesivir EUA provisions on advertising and promotion
In the News · Source: Bloomberg Law
April 28, 2020
David Farber comments on home health agencies and lawmakers' call for policy change to make IV drugs easier for patients to get at home
In the News · Source: Bloomberg Law
In the News · Source: Pink Sheet
March 22, 2020
Lisa Dwyer comments on proposed COVID-19 provisions moving through Congress
In the News · Source: CNN
In the News · Source: Law360
March 6, 2020
FDA practice profiled as head of the practice Mark Brown highlights policy issues to watch
In the News · Source: Pink Sheet
February 11, 2020
David Farber comments on the next round of biomedical innovation legislation
Recognition
February 11, 2020
Law360 Names King & Spalding a 2019 Life Sciences Practice Group of the Year for the Fourth Consecutive Year
In the News · Source: Medtech Insight
October 17, 2019
Eric Henry explains why device-makers should consider the cumulative effect of software cyber security patches on products